US Patent 11452725 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Bristol Laboratories Ltd

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Bristol Laboratories Ltd

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 44 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
44 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

4 All APIs, 3 USDMF, 1 CEP/COS

4 All APIs
3 USDMF
1 CEP/COS

FINISHED DOSAGE FORMULATIONS

95 FDF Dossiers, 83 FDA Orange Book, 12 Europe

95 FDF Dossiers
83 FDA Orange Book
12 Europe

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4BRISTOL

filter Patent Number Reset all filters

4 All

01 411452725

API Patent Reset all filters

4 All

01 4Blank

FDF Patent Reset all filters

4 All

01 4Blank

filter Expiration Date Reset all filters

4 All

01 42036-07-24

01

BRISTOL

BioProcess International US West

Not Confirmed

BRISTOL

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-24

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3755

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BRISTOL

BioProcess International US West

Not Confirmed

BRISTOL

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-24

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3961

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BRISTOL

BioProcess International US West

Not Confirmed

BRISTOL

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-24

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3961

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BRISTOL

BioProcess International US West

Not Confirmed

BRISTOL

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-24

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3755

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.